Correlation Between 209111GE7 and Inhibrx
Specify exactly 2 symbols:
By analyzing existing cross correlation between ED 52 01 MAR 33 and Inhibrx, you can compare the effects of market volatilities on 209111GE7 and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 209111GE7 with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of 209111GE7 and Inhibrx.
Diversification Opportunities for 209111GE7 and Inhibrx
Very weak diversification
The 3 months correlation between 209111GE7 and Inhibrx is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding ED 52 01 MAR 33 and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and 209111GE7 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ED 52 01 MAR 33 are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of 209111GE7 i.e., 209111GE7 and Inhibrx go up and down completely randomly.
Pair Corralation between 209111GE7 and Inhibrx
Assuming the 90 days trading horizon 209111GE7 is expected to generate 6.83 times less return on investment than Inhibrx. But when comparing it to its historical volatility, ED 52 01 MAR 33 is 1.63 times less risky than Inhibrx. It trades about 0.06 of its potential returns per unit of risk. Inhibrx is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 1,493 in Inhibrx on October 9, 2024 and sell it today you would earn a total of 159.00 from holding Inhibrx or generate 10.65% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 94.74% |
Values | Daily Returns |
ED 52 01 MAR 33 vs. Inhibrx
Performance |
Timeline |
209111GE7 |
Inhibrx |
209111GE7 and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 209111GE7 and Inhibrx
The main advantage of trading using opposite 209111GE7 and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 209111GE7 position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.209111GE7 vs. AEP TEX INC | 209111GE7 vs. US BANK NATIONAL | 209111GE7 vs. Moelis Co | 209111GE7 vs. Pure Storage |
Inhibrx vs. Ginkgo Bioworks Holdings | Inhibrx vs. CureVac NV | Inhibrx vs. Iovance Biotherapeutics | Inhibrx vs. Krystal Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |